Carlson Capital’s Checkpoint Therapeutics CKPT Stock Holding History

Carlson Capital’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-60,000	Closed	-$242K	–	69
2025 Q1	$242K	Buy	+60,000	New	+$200K	0.09%	40

Carlson Capital's CKPT Position: Q2 2025 in Review

Carlson Capital sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 60,000 shares — an estimated $242K sold.

Carlson Capital first reported a position in CKPT in Q1 2025 and held it in 1 quarter. The position peaked at $242K in Q1 2025. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

Carlson Capital reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
Carlson Capital sold 60,000 Checkpoint Therapeutics shares in Q2 2025, an estimated $242K.
Carlson Capital first reported a position in Checkpoint Therapeutics in Q1 2025 and held it in 1 quarter.
Carlson Capital's Checkpoint Therapeutics position peaked at $242K in Q1 2025.
0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on Carlson Capital's 13F filing for Q2 2025, filed 13 Aug 2025.